9 Meters Biopharma Inc NMTR shares are trading lower by 13.1% to $0.18 Monday morning after the company announced a 1-for-20 reverse stock split.
9 Meters Biopharma says the reverse stock split was previously approved by 9 Meters stockholders at the annual meeting of stockholders held on June 22, 2022, with the final ratio determined by the Company’s Board of Directors.
9 Meters Biopharma says the reverse stock split is intended to bring the company into compliance with Nasdaq’s minimum bid price requirement. Common stock will begin trading on a split-adjusted basis commencing upon market open on October 18.
See Also: As China Weakness, PC Market Downturn Take Toll On Semiconductor Sector Ahead Of Q3 Results, Analyst Recommends These Chip Stocks
According to data from Benzinga Pro, 9 Meters Biopharma has a 52-week high of $1.35 and a 52-week low of $0.16.
Image and article originally from www.benzinga.com. Read the original article here.